You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tucatinib

Showing 26 - 50 of 59
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Kinase Inhibitor Targeted Therapies

Not yet recruiting
  • Blood Concentrations of Nine Anti-cancer Drugs : Axitinib, Olaparib, regorafénib, Cabozantinib, Niraparib, Talazoparib, Palbociclib, Abemaciclib, Tucatinib
  • Measurement of drug concentrations
  • Rennes, France
  • +2 more
Nov 7, 2022

Metastatic Breast Cancer, Leptomeningeal Disease Trial in United States (Tucatinib, Trastuzumab, Capecitabine)

Active, not recruiting
  • Metastatic Breast Cancer
  • Leptomeningeal Disease
  • Tucatinib
  • +2 more
  • Birmingham, Alabama
  • +8 more
Oct 12, 2021

HER2 Positive Breast Cancer Trial in United States (tucatinib, trastuzumab deruxtecan)

Recruiting
  • HER2 Positive Breast Cancer
  • tucatinib
  • trastuzumab deruxtecan
  • Birmingham, Alabama
  • +32 more
Oct 26, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma Trial in Worldwide (tucatinib,

Active, not recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • tucatinib
  • +5 more
  • Birmingham, Alabama
  • +47 more
Oct 27, 2022

Breast Cancer Trial in Japan, Korea, Republic of, Taiwan (Tucatinib, Trastuzumab, Capecitabine)

Active, not recruiting
  • Breast Cancer
  • Tucatinib
  • +2 more
  • Nagoya, Aichi, Japan
  • +27 more
Nov 30, 2022

Breast Cancer Trial (Tucatinib, Abemaciclib, Trastuzumab)

Withdrawn
  • Breast Cancer
  • Tucatinib
  • +3 more
  • (no location specified)
Oct 21, 2020

HER2-expressing Cancers Trial in Canada, Korea, Republic of, United States (ZW25 (Zanidatamab), Paclitaxel, Capecitabine)

Active, not recruiting
  • HER2-expressing Cancers
  • ZW25 (Zanidatamab)
  • +4 more
  • Birmingham, Alabama
  • +16 more
Feb 25, 2022

Uterine Tumors, Uterine Cervical Tumors, Biliary Tract Tumors Trial in Worldwide (tucatinib, trastuzumab, fulvestrant)

Recruiting
  • Uterine Neoplasms
  • +5 more
  • tucatinib
  • +2 more
  • Goodyear, Arizona
  • +63 more
Aug 15, 2022

Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in Canada (Olaparib, Dasatinib, Nivolumab plus Ipilimumab)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Edmonton, Alberta, Canada
  • +9 more
Jan 9, 2023

HER2-positive Breast Cancer Trial (Tucatinib, Capecitabine, Trastuzumab)

Approved for marketing
  • HER2-positive Breast Cancer
  • Tucatinib
  • +2 more
  • (no location specified)
May 5, 2020

HER2 Positive Breast Cancers Trial in Canada, United States (Tucatinib (ONT-380), T-DM1)

Completed
  • HER2 Positive Breast Cancers
  • Birmingham, Alabama
  • +10 more
Sep 17, 2020

HER2 Positive Metastatic Breast Cancers Trial in United States (Tucatinib, Capecitabine, Trastuzumab)

Completed
  • HER2 Positive Metastatic Breast Cancers
  • Tucatinib
  • +2 more
  • Aurora, Colorado
  • +4 more
Jun 2, 2020

Trial (Tucatinib)

No longer available
    • Tucatinib
    • (no location specified)
    Feb 21, 2020

    HER2 Positive Breast Cancer Trial in Worldwide (Tucatinib, Trastuzumab, Pertuzumab)

    Recruiting
    • HER2 Positive Breast Cancer
    • Tucatinib
    • +4 more
    • Phoenix, Arizona
    • +143 more
    Jan 20, 2023

    HER2-positive Breast Cancer, Brain Metastases Trial in Beijing, Guangzhou, Hangzhou (Trastuzumab, Taxanes, Pertuzumab)

    Not yet recruiting
    • HER2-positive Breast Cancer
    • Brain Metastases
    • Beijing, Beijing, China
    • +2 more
    May 28, 2021

    HER2-positive Breast Cancer Trial in Worldwide (tucatinib, , T-DM1)

    Recruiting
    • HER2-positive Breast Cancer
    • tucatinib
    • +2 more
    • Mobile, Alabama
    • +262 more
    Jan 26, 2023

    Drug-drug Interaction Trial in Daytona Beach, Dallas (tucatinib, itraconazole, rifampin)

    Completed
    • Drug-drug Interaction
    • tucatinib
    • +7 more
    • Daytona Beach, Florida
    • +1 more
    Dec 16, 2019

    Healthy Trial in Glendale (Tucatinib)

    Completed
    • Healthy
    • Tucatinib
    • Glendale, California
      PAREXEL International, Early Phase Clinical Unit - Los Angeles
    Sep 3, 2019

    Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Durvalumab, Paclitaxel)

    Recruiting
    • Metastatic Breast Cancer
    • Trastuzumab deruxtecan
    • +4 more
    • West Hollywood, California
    • +101 more
    Jan 16, 2023

    Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG

    Recruiting
    • Breast Neoplasms
    • +10 more
    • Standard Therapy
    • +32 more
    • Birmingham, Alabama
    • +35 more
    Nov 17, 2022

    Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8 Trial

    Recruiting
    • Anatomic Stage IA Breast Cancer AJCC v8
    • +21 more
    • Trastuzumab Emtansine
    • +4 more
    • Birmingham, Alabama
    • +897 more
    Feb 16, 2022

    Healthy Trial in Dallas (tucatinib, , moxifloxacin)

    Completed
    • Healthy
    • tucatinib
    • +2 more
    • Dallas, Texas
      Covance Clinical Research Unit - Dallas
    Apr 11, 2019

    Advanced Unresectable or Metastatic Solid Malignancy Trial in United States (Entrectinib, Inavolisib, Alectinib)

    Recruiting
    • Advanced Unresectable or Metastatic Solid Malignancy
    • Birmingham, Alabama
    • +50 more
    Aug 10, 2022

    Hepatic Impairment Trial in United States (Tucatinib)

    Completed
    • Hepatic Impairment
    • Tucatinib
    • Tustin, California
    • +3 more
    May 16, 2019

    Drug-drug Interaction Trial in Salt Lake City (Tucatinib, Metformin, Iohexol)

    Completed
    • Drug-drug Interaction
    • Tucatinib
    • +2 more
    • Salt Lake City, Utah
      Pharmaceutical Research Associates
    Mar 25, 2019